Cas:60733-16-6 5-amino-2-hydrazinopentanoic acid hydrochloride manufacturer & supplier

Chemical Name:5-amino-2-hydrazinopentanoic acid hydrochloride

CAS.NO:60733-16-6

Synonyms:A-hydrazinoornithine hydrochloride;5-amino-2-hydrazinopentanoic acid

Molecular Formula:C₅H₁₄ClN₃O₂

Molecular Weight:183.63700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:375ºC at 760 mmHg

Density:1.204g/cm3

Index of Refraction:1.523

PSA:101.37000

Exact Mass:183.07700

LogP:1.23530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like A-hydrazinoornithine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-amino-2-hydrazinopentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-amino-2-hydrazinopentanoic acid Use and application,A-hydrazinoornithine hydrochloride technical grade,usp/ep/jp grade.

Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 5-amino-2-hydrazinopentanoic acid hydrochloride manufacturer With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. 5-amino-2-hydrazinopentanoic acid hydrochloride supplier With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. 5-amino-2-hydrazinopentanoic acid hydrochloride vendor The New York Times said that the batches being discarded amount to around 60 million doses, citing people familiar with the matter. 5-amino-2-hydrazinopentanoic acid hydrochloride factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.